APOHEALTH SORE THROAT LOZENGES PLUS ANAESTHETIC blister pack

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

lidocaine hydrochloride monohydrate, Quantity: 4 mg; benzydamine hydrochloride, Quantity: 3 mg; dichlorobenzyl alcohol, Quantity: 1.2 mg

Disponibbli minn:

Nova Pharmaceuticals Australasia Pty Ltd

INN (Isem Internazzjonali):

Benzydamine hydrochloride,Dichlorobenzyl alcohol,lidocaine (lignocaine) hydrochloride monohydrate

Għamla farmaċewtika:

Lozenge

Kompożizzjoni:

Excipient Ingredients: quinoline yellow; purified water; sucralose; isomalt; menthol; citric acid; ethanol absolute; Flavour

Rotta amministrattiva:

Oromucosal

Unitajiet fil-pakkett:

12, 16, 24, 32, 36, 48

Tip ta 'preskrizzjoni:

Not Scheduled after consideration by Committee

Indikazzjonijiet terapewtiċi:

For the relief of major symptoms associated with sore throat. Reduces inflammation and relieves pain for fast effective relief of symptoms of a sore throat, oral surgery, minor mouth infections and dental procedures.

Sommarju tal-prodott:

Visual Identification: A yellow coloured, round, flat bevelled lozenges.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2017-04-26